J. Henri Bayle
Chief Tech/Sci/R&D Officer bij BELLICUM PHARMACEUTICALS, INC.
Profiel
J.
Henri Bayle is currently working as the Vice President-Research at Bellicum Pharmaceuticals, Inc. He completed his undergraduate degree from the University of Alberta and his doctorate from Princeton University.
Actieve functies van J. Henri Bayle
| Bedrijven | Functie | Begin |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2014 |
Opleiding van J. Henri Bayle
| University of Alberta | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
